Topiramate and Kidney Protection: A Serendipitous Connection?
Authors:
Open Access
- 14 June 2025
- journal article
- Published by Elsevier in Kidney International Reports
- Vol. 10 (8) , 2530-2532
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Risk of End-Stage Kidney Disease and Topiramate UseKidney International Reports, 2025
- Modulating oxidative stress and neurogenic inflammation: the role of topiramate in migraine treatmentFrontiers in Aging Neuroscience, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- A novel functional role for the classic CNS neurotransmitters, GABA, glycine, and glutamate, in the kidney: potent and opposing regulators of the renal vasculatureAmerican Journal of Physiology-Renal Physiology, 2023
- Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF SystemInternational Journal of Molecular Sciences, 2022
- FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic MigraineHeadache: The Journal of Head and Face Pain, 2019
- Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipidsPharmacological Research, 2019
- Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort studyBMJ Open, 2017
- Topiramate in Migraine PreventionHeadache: The Journal of Head and Face Pain, 2005